McGuff Pharmaceuticals

McGuff Pharmaceuticals

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

McGuff Pharmaceuticals is a long-established, private contract manufacturer focused on sterile injectables and clinical trial services. Its core competency lies in FDA cGMP-compliant manufacturing, leveraging a vertically integrated model through alliance partners for compounding and distribution. The company is capitalizing on the growing outsourcing trend in pharma by expanding its physical capacity and service offerings to provide cost-effective, quality manufacturing solutions for both clinical-stage and commercial clients.

Drug DeliverySmall Molecules

Technology Platform

FDA cGMP-compliant aseptic liquid fill-finish manufacturing platform for sterile injectable drugs, with integrated R&D, formulation, and regulatory services.

Opportunities

The expanding global CDMO market, especially for complex sterile injectables, offers significant growth potential.
The construction of a new, larger, state-of-the-art facility will provide increased capacity to capture more business from both existing and new clients in the biotech and generic pharma sectors.

Risk Factors

Major risks include regulatory compliance failures at its manufacturing facilities, which could halt operations, and intense competition in the CDMO space potentially squeezing margins.
The company also faces execution risk associated with the construction and validation of its new plant.

Competitive Landscape

McGuff competes in the fragmented contract manufacturing space for sterile injectables, facing competition from large global CDMOs (e.g., Catalent, Lonza), other specialized US-based manufacturers, and the in-house capabilities of large pharmaceutical companies. Its differentiation lies in its integrated service model with allied compounding and distribution partners, and its focus on the US market.